Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Neurooncol. 2018 Jan 4;137(2):249–257. doi: 10.1007/s11060-017-2732-1

Table 4.

Primary versus recurrent GBM sample continuous variables.

Variable Group n Mean (yrs
or %
positive
staining)
SD p value
Age Primary 38 61.05 10.67 0.0009
Recurrent 11 43.36 12.71
CD3 Primary 37 0.35 0.44 0.9416
Recurrent 11 0.33 0.35
CD8 Primary 36 0.12 0.14 0.1937
Recurrent 11 0.30 0.44
CD68 Primary 38 5.20 3.39 0.7120
Recurrent 11 5.46 2.06
CD163 Primary 38 6.12 6.40 0.7658
Recurrent 11 5.56 3.72
FOXP3 Primary 37 0.35 0.47 0.9279
Recurrent 10 0.37 0.47
PDL1 Primary 37 8.11 7.66 0.4508
Recurrent 11 7.42 4.34
CTLA4 Primary 38 0.43 0.59 0.9525
Recurrent 11 0.27 0.23
CD70 Primary 34 0.69 1.38 0.3401
Recurrent 6 0.82 0.79
PD1 Primary 38 1.42 × 105 3.95 × 105 0.4888
Recurrent 11 0.38 × 105 0.75 × 105

The patient age and percent positive cell expression of immune markers are shown in primary and recurrent samples. The primary samples were associated with older patients compared to recurrent samples. No significant differences in immune marker expression was found between primary and recurrent samples.